David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Advanced Energy
AEIS
$11B
| $360K | ﹤0.01% |
+14,012
| New | +$357K |
|
|
DRNA
3202
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $360K | ﹤0.01% |
14,978
-6,680
| -31% | -$150K |
|
3203
Scorpio Tankers
STNG
$3.87B
| $359K | ﹤0.01% |
+3,811
| New | +$332K |
|
3204
Ventas
VTR
$48.1B
| $359K | ﹤0.01% |
4,306
-15,960
| -79% | -$1.37M |
|
3205
Orion Group Holdings
ORN
$378M
| $357K | ﹤0.01% |
40,248
+30,001
| +293% | +$288K |
|
3206
Southwest Gas
SWX
$6.45B
| $356K | ﹤0.01% |
+6,124
| New | +$362K |
|
3207
PUT
Tenet Healthcare
THC
$21.9B
| $356K | ﹤0.01% |
7,200
-12,300
| -63% | -$575K |
|
|
SRDX
3208
DELISTED
Surmodics
SRDX
| $354K | ﹤0.01% |
13,617
+2,468
| +22% | +$58.8K |
|
|
XCO
3209
DELISTED
Exco Resources
XCO
| $354K | ﹤0.01% |
12,914
+7,589
| +143% | +$224K |
|
3210
CoreCivic
CXW
$3.28B
| $352K | ﹤0.01% |
+8,742
| New | +$344K |
|
3211
Horace Mann Educators
HMN
$2.07B
| $352K | ﹤0.01% |
+10,289
| New | +$331K |
|
3212
CALL
Sprouts Farmers Market
SFM
$8.01B
| $352K | ﹤0.01% |
10,000
| – | – |
|
3213
Nordson
NDSN
$18.6B
| $350K | ﹤0.01% |
+4,463
| New | +$338K |
|
|
BAS
3214
PUT
DELISTED
Basis Energy Services, Inc.
BAS
| $347K | ﹤0.01% |
88
-5
| -5% | -$18.8K |
|
3215
ProQR Therapeutics
PRQR
$336M
| $346K | ﹤0.01% |
+15,806
| New | +$326K |
|
|
CTG
3216
DELISTED
Computer Task Group, Inc.
CTG
| $345K | ﹤0.01% |
47,177
-2,213
| -4% | -$17.6K |
|
|
BIOL
3217
DELISTED
Biolase, Inc.
BIOL
| $343K | ﹤0.01% |
14
+6
| +75% | +$170K |
|
|
DWA
3218
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $343K | ﹤0.01% |
14,164
-14,100
| -50% | -$300K |
|
3219
Akamai
AKAM
$15.2B
| $341K | ﹤0.01% |
4,800
-43,560
| -90% | -$2.88M |
|
3220
AES
AES
$10.5B
| $340K | ﹤0.01% |
+26,486
| New | +$332K |
|
|
GOOD
3221
Gladstone Commercial Corp
GOOD
$635M
| $340K | ﹤0.01% |
18,268
-3,996
| -18% | -$71.3K |
|
3222
Perion Network
PERI
$385M
| $340K | ﹤0.01% |
33,764
-7,734
| -19% | -$79.5K |
|
|
ROSE
3223
PUT
DELISTED
ROSETTA RESOURCES INC
ROSE
| $340K | ﹤0.01% |
+20,000
| New | +$383K |
|
3224
Casella Waste Systems
CWST
$5.95B
| $339K | ﹤0.01% |
61,724
-28,298
| -31% | -$122K |
|
3225
Sony
SONY
$141B
| $339K | ﹤0.01% |
63,210
-376,475
| -86% | -$1.9M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.